Hong Kong healthcare stocks continue to rise, with Hybio Pharmaceutical surging almost 46%.

As of press time, YaoJieAnkang-B increased by 45.78%, Tongyuan Kangyao-B increased by 7.88%, Vitasoy-B increased by 6.26%, and China Antibody-B increased by 5.76%.